Copyright
©The Author(s) 2017.
World J Gastroenterol. Apr 7, 2017; 23(13): 2318-2329
Published online Apr 7, 2017. doi: 10.3748/wjg.v23.i13.2318
Published online Apr 7, 2017. doi: 10.3748/wjg.v23.i13.2318
Parameter | n | CUL4A IHC score | P value |
Age (yr) | 0.902 | ||
< 65 | 54 | 4.07 ± 2.46 | |
≥ 65 | 24 | 3.99 ± 2.47 | |
Gender | 0.606 | ||
Male | 45 | 3.92 ± 2.34 | |
Female | 33 | 4.21 ± 2.62 | |
Tumour size (cm) | 0.330 | ||
< 3 | 36 | 3.75 ± 2.55 | |
≥ 3 | 42 | 4.30 ± 2.36 | |
Differentiation grade | < 0.001 | ||
Well + moderate | 66 | 3.56 ± 2.30 | |
Poor + undifferentiated | 12 | 6.68 ± 1.24 | |
T stage | 0.001 | ||
T1 + T2 | 63 | 3.62 ± 2.34 | |
T3 + T4 | 15 | 5.81 ± 2.12 | |
N stage | < 0.001 | ||
N0 | 64 | 3.35 ± 2.08 | |
N1 + N2 | 14 | 7.21 ± 1.13 | |
M stage | 0.980 | ||
M0 | 76 | 4.04 ± 2.46 | |
M1 | 2 | 4.00 ± 2.83 | |
TNM stage | < 0.001 | ||
I + II | 54 | 3.14 ± 2.03 | |
III + IV | 24 | 6.08 ± 2.07 |
Parameter | Overall survival | Progression-free survival | ||||
HR | 95%CI | P value | HR | 95%CI | P value | |
Univariate analysis | ||||||
Age: ≥ 65 yr vs < 65 yr | 1.218 | 0.676-2.193 | 0.512 | 1.097 | 0.616-1.954 | 0.753 |
Gender: male vs female | 1.003 | 0.569-1.767 | 0.993 | 0.931 | 0.538-1.610 | 0.798 |
Differentiation: well + moderate vs poor + undifferentiated | 0.432 | 0.171-1.092 | 0.076 | 0.461 | 0.196-1.083 | 0.075 |
Tumour size: ≥ 3 cm vs < 3 cm | 1.049 | 0.598-1.839 | 0.869 | 1.008 | 0.586-1.733 | 0.977 |
T stage: (T3 + T4) vs (T1 + T2) | 2.181 | 1.129-4.213 | 0.020 | 1.871 | 0.977-3.583 | 0.059 |
N stage: N1 + N2 vs N0 | 3.120 | 1.613-6.036 | 0.001 | 2.917 | 1.515-5.619 | 0.001 |
M stage: M1 vs M0 | 4.761 | 0.54-38.170 | 0.142 | 2.766 | 0.363-21.092 | 0.326 |
TNM stage: (III + IV) vs (I + II) | 3.001 | 1.671-5.387 | < 0.001 | 2.729 | 1.538-4.842 | 0.001 |
CUL4A: high vs low | 2.823 | 1.577-5.053 | < 0.001 | 2.964 | 1.691-5.196 | < 0.001 |
Multivariate analysis | ||||||
T stage: (T3 + T4) vs (T1 + T2) | 0.811 | 0.271-2.424 | 0.708 | - | - | - |
N stage: N1 + N2 vs N0 | 0.969 | 0.305-3.081 | 0.957 | 1.106 | 0.428-2.857 | 0.836 |
TNM stage: (III + IV) vs (I + II) | 2.483 | 0.632-9.752 | 0.193 | 1.699 | 0.735-3.928 | 0.215 |
CUL4A: high vs low | 2.117 | 1.086-4.125 | 0.028 | 2.248 | 1.240-4.446 | 0.009 |
- Citation: Zhang TJ, Xue D, Zhang CD, Zhang ZD, Liu QR, Wang JQ. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma. World J Gastroenterol 2017; 23(13): 2318-2329
- URL: https://www.wjgnet.com/1007-9327/full/v23/i13/2318.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i13.2318